STX1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 9 NGS Genetic DNA Test
Comprehensive Genetic Testing for Epilepsy Disorders
The STX1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 9 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the STX1B gene, which plays a crucial role in neurotransmitter release and synaptic function. Understanding the genetic basis of seizure disorders enables healthcare providers to deliver personalized care and accurate prognosis for patients and their families.
What Does This Test Measure?
This sophisticated genetic analysis detects specific mutations in the STX1B gene using Next-Generation Sequencing (NGS) technology. The test identifies:
- Pathogenic variants in the STX1B gene associated with Generalized Epilepsy with Febrile Seizures Plus (GEFS+)
- Genetic mutations affecting syntaxin-binding protein 1B function
- Variants that disrupt neurotransmitter release mechanisms
- Inheritance patterns for genetic counseling purposes
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Unexplained recurrent seizures or convulsions
- Febrile seizures that persist beyond early childhood
- Family history of epilepsy or seizure disorders
- Multiple seizure types within the same individual
- Seizures triggered by fever or illness
- Developmental delays associated with seizure activity
Clinical Benefits of Genetic Epilepsy Testing
Undergoing the STX1B gene test provides numerous advantages:
- Accurate Diagnosis: Confirms genetic basis of seizure disorders
- Personalized Treatment: Enables targeted medication selection
- Family Planning: Provides crucial information for genetic counseling
- Prognostic Insights: Helps predict disease progression and severity
- Early Intervention: Facilitates timely management strategies
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:
- Positive Result: Indicates presence of STX1B gene mutation associated with GEFS+
- Negative Result: No detected mutation in the STX1B gene
- Variant of Uncertain Significance: Requires additional family studies
- Carrier Status: Important for family planning decisions
All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | STX1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 9 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before scheduling your test, please ensure:
- Complete clinical history documentation
- Genetic counseling session to create family pedigree chart
- Discussion of testing implications with healthcare provider
- Understanding of potential results and their meaning
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about seizure disorders control your life. The STX1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 9 NGS Genetic DNA Test provides the clarity needed for effective management and treatment planning. Our expert team of neurologists and genetic counselors are ready to support you through every step of the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic epilepsy test and take the first step toward understanding your neurological health.
